Cision PR Newswire, Author at World Lifestyler

No Result

View All Result

WORLD LIFESTYLER

No Result

View All Result

Home Author

Cision PR Newswire

Press Releases - Lifestyle

46 Greenberg Traurig Attorneys Recognized in 2026 IAM Patent 1000

June 6, 2026

Press Releases - Lifestyle

Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control

June 6, 2026

Press Releases - Travel

The City of Hallandale Beach Among 10 Finalists for Climate Protection from US Conference of Mayors; Cloud Receives Small City Award

June 5, 2026

Press Releases - Lifestyle

Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlite™ in Landmark CREDENCE Trial

June 5, 2026

Press Releases - Lifestyle

Machine Learning Model Accurately Predicts Long-Term Risk of Type 2 Diabetes

June 5, 2026

Press Releases - Lifestyle

Ambrosia Biosciences Announces Preclinical Data Supporting Differentiated Profile of AMB-702, its Novel Small Molecule GLP-1 Receptor Agonist Development Candidate

June 5, 2026

Press Releases - Lifestyle

Novo Nordisk’s investigational zenagamtide shows significant A1C reductions with up to 14.6% weight loss in adults with type 2 diabetes–presented at ADA 2026

June 5, 2026

Press Releases

Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

June 5, 2026

Press Releases - Food & Drink

Corner Bakery Offers $50 Off Catering for Game-Day Watch Parties

June 5, 2026

Press Releases - Lifestyle

First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control

June 5, 2026

Page 1017 of 3923 Prev 1 … 1,016 1,017 1,018 … 3,923 Next

No Result

View All Result

Home

Cision PR Newswire

46 Greenberg Traurig Attorneys Recognized in 2026 IAM Patent 1000

Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control

The City of Hallandale Beach Among 10 Finalists for Climate Protection from US Conference of Mayors; Cloud Receives Small City Award

Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlite™ in Landmark CREDENCE Trial

Machine Learning Model Accurately Predicts Long-Term Risk of Type 2 Diabetes

Ambrosia Biosciences Announces Preclinical Data Supporting Differentiated Profile of AMB-702, its Novel Small Molecule GLP-1 Receptor Agonist Development Candidate

Novo Nordisk’s investigational zenagamtide shows significant A1C reductions with up to 14.6% weight loss in adults with type 2 diabetes–presented at ADA 2026

Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Corner Bakery Offers $50 Off Catering for Game-Day Watch Parties

First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control

Recommended

Northborne Partners Advises Sierra Railroad Company on its Sale to Ridgewood Infrastructure

ICI Partnership with America250 Spotlights 76 Million Households Building Wealth Through Funds

Popular News

ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

ZoomInfo Technologies Inc. (GTM) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BYAH Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against Park Ha Biological Technology Co., Ltd.

Daily Union News: M Beauty Gallery’s Miok Kim Builds Integrated Care Model Connecting Inner and Outer Well-Being…from Skin Structure to Life Structure

Are CBZ, SAFT, NEUP Obtaining Fair Deals for their Shareholders?

Connect with us

About & Contact

Explore Content

Legal & Privacy

Tiny Media Brands